Literature DB >> 8522058

Effect of prostaglandin E2 and hyaluronan on mesangial cell proliferation. A potential contribution to glomerular hypercellularity in diabetes.

P Mahadevan1, R G Larkins, J R Fraser, M E Dunlop.   

Abstract

Proliferation of mesangial cells is a feature of several forms of human and experimental glomerulopathy, including that seen in diabetes. The nonsulfated glycosaminoglycan hyaluronan participates in the regulation of pericellular matrix assembly and is a mitogen in some cell types. We have shown previously that hyaluronan production is increased in the glomerulus in a glucose- and prostaglandin-dependent manner. We have investigated the effect of diabetes and of addition of hyaluronan and prostaglandin E2 (PGE2) on the uptake of [3H]thymidine by glomerular core preparations enriched in mesangial cells. When compared with nondiabetic controls, it was shown that [3H]thymidine uptake was significantly increased in glomerular core preparations from streptozotocin-induced diabetic rats (to 169 +/- 5%, P < 0.001). In glomerular cores from both experimental groups, hyaluronan (50-250 ng/ml) or PGE2 (10(-12) to 10(-8) mol/l) increased the uptake of [3H]thymidine. Further, mesangial cells from nondiabetic control glomerular cores, when maintained in culture in early passage, responded with increased [3H]thymidine uptake to raised glucose (5.6-25 mmol/l) and to added hyaluronan and PGE2. We propose that prostaglandin and hyaluronan production in response to a raised glucose environment in diabetes can contribute to mesangial hypercellularity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8522058     DOI: 10.2337/diab.45.1.44

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production.

Authors:  A M Sheridan; T Force; H J Yoon; E O'Leary; G Choukroun; M R Taheri; J V Bonventre
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 2.  Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

Authors:  Anna Alexanian; Andrey Sorokin
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

Review 3.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Hyaluronan induces the selective accumulation of matrix- and cell-associated proteoglycans by mesangial cells.

Authors:  Sabine Kastner; Gareth J Thomas; Robert H Jenkins; Malcolm Davies; Robert Steadman
Journal:  Am J Pathol       Date:  2007-11-01       Impact factor: 4.307

5.  Antiproliferative effect of fluvastatin and thiazolidinedione in mesangial cells of diabetic rats.

Authors:  Mitsuru Okada; Hidehiko Yanagida; Hiroaki Kuwajima; Tsukasa Takemura
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

Review 6.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

7.  Insulin regulates SOCS2 expression and the mitogenic effect of IGF-1 in mesangial cells.

Authors:  Keiji Isshiki; Zhiheng He; Yasuhiro Maeno; Ronald C Ma; Yutaka Yasuda; Tatsuya Kuroki; Gregory S White; Mary E Patti; Gordon C Weir; George L King
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

8.  d-allulose protects against diabetic nephropathy progression in Otsuka Long-Evans Tokushima Fatty rats with type 2 diabetes.

Authors:  Misato Niibo; Akane Kanasaki; Tetsuo Iida; Keisuke Ohnishi; Taro Ozaki; Kazuya Akimitsu; Tetsuo Minamino
Journal:  PLoS One       Date:  2022-01-31       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.